These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3411630)

  • 21. Therapeutic efficacy of bis-pyridinium oximes against diisopropyl fluorophosphate (DFP) and soman intoxication in rodents.
    Dube SN; Kumar D; Sikder AK; Sikder N; Jaiswal DK; Das Gupta S
    Pharmazie; 1992 Jan; 47(1):68-9. PubMed ID: 1608992
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuromuscular dysfunction induced by acetylcholinesterase inhibition.
    Wecker L; Laskowski B; Dettbarn WD
    Fed Proc; 1978 Dec; 37(14):2818-22. PubMed ID: 214351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
    Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
    Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon.
    Thiermann H; Eyer P; Worek F; Szinicz L
    Toxicology; 2005 Oct; 214(3):190-7. PubMed ID: 16040183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reversal by pyridostigmine of neuromuscular block produced by soman.
    French MC; Wetherell JR; White PD
    J Pharm Pharmacol; 1979 May; 31(5):290-4. PubMed ID: 37297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman.
    Dillman JF; Phillips CS; Kniffin DM; Tompkins CP; Hamilton TA; Kan RK
    Chem Res Toxicol; 2009 Apr; 22(4):633-8. PubMed ID: 19281266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
    Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
    Kassa J
    Ceska Slov Farm; 1999 Jan; 48(1):44-7. PubMed ID: 10376416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro.
    Herkert NM; Schulz S; Wille T; Thiermann H; Hatz RA; Worek F
    Toxicol Appl Pharmacol; 2011 May; 253(1):7-13. PubMed ID: 21402092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
    Lucić Vrdoljak A; Radić B; Garaj-Vrhovac V; Kopjar N; Zlender V
    J Appl Toxicol; 2006; 26(1):56-63. PubMed ID: 16167315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
    Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
    Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypersensitivity to antimuscarinic agents following brief exposure to Soman and Sarin.
    Fernando JC; Hoskins B; Ho IK
    J Toxicol Environ Health; 1986; 18(1):103-9. PubMed ID: 3701876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
    Fernando JC; Lim DK; Hoskins B; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
    Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel.
    Hanke DW; Overton MA
    J Toxicol Environ Health; 1991 Sep; 34(1):141-56. PubMed ID: 1890690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms involved in the development of tolerance to DFP toxicity.
    Gupta RC; Patterson GT; Dettbarn WD
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diisopropylphosphorofluoridate-induced muscle hyperactivity associated with enhanced lipid peroxidation in vivo.
    Yang ZP; Morrow J; Wu A; Roberts LJ; Dettbarn WD
    Biochem Pharmacol; 1996 Jul; 52(2):357-61. PubMed ID: 8694861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of high-energy phosphate compounds in the skeletal muscles of rats intoxicated with diisopropylphosphorofluoridate (DFP) and Soman.
    Gupta RC; Dettbarn WD
    Fundam Appl Toxicol; 1987 Apr; 8(3):400-7. PubMed ID: 3569710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pesticide induced muscle necrosis: mechanisms and prevention.
    Dettbarn WD
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S18-26. PubMed ID: 6724209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.